Alex Cuenca | Medical Services
Specialties
- Biliary Atresia
- Choledochal Cysts
- Chronic Lung Disease of Prematurity
- Circumcision
- Cirrhosis
- Fatty Liver
- Gastroschisis
- Germ Cell Tumors
- Hepatoblastoma
- Hepatocellular Carcinoma
- Hydrocele
- Intestinal Atresia and Stenosis
- Intraventricular Hemorrhage
- Intussusception
- Lung Resection
- Minimally Invasive Surgery
- Necrotizing Enterocolitis
- Omphalocele
- Polycystic Kidney Disease
- Pyloric Stenosis
Programs & Services
- Kidney Tumor Program
- Liver Tumor Center
- Midaortic Syndrome and Renovascular Hypertension Center
- Pancreatic Disorders Program
- Pediatric Transplant Center
- Surgery
Languages
- English
- Spanish
Alex Cuenca | Education
Undergraduate School
New College
1997, Sarasota, FL
Medical School
University of Florida
2006, Gainesville, FL
Internship
Shands Teaching Hospital/ University of Florida
2007, Gainesville, FL
Graduate School
University of Florida
2012, Gainesville, FL
Residency
Shands Teaching Hospital/ University of Florida
2015, Gainesville, FL
Fellowship
Boston Children's Hospital
2017, Boston, MA
Fellowship
Massachusetts General Hospital
2019, Boston, MA
Alex Cuenca | Certifications
- American Board of Surgery (General)
- American Board of Surgery (Pediatric Surgery)
Alex Cuenca | Professional History
Dr. Cuenca completed his medical school, graduate school, and residency at the University of Florida in Gainesville, Fl. During his research hiatus in residency, he obtained a PhD examining the role of innate immunity and toll-like receptor signaling in neonatal sepsis. He then went on to complete a fellowship in Pediatric Surgery at Boston Children’s Hospital. Due to his interest in pediatric hepatobiliary disease and transplant medicine, he went on to complete a fellowship in Transplant Surgery at Massachusetts General Hospital. He is clinically interested in pediatric hepatobiliary and pancreatic disease, solid organ transplantation, mid-aortic vascular disease, and other general surgical conditions of children. His research efforts are focused on examining the role of innate immunity in allograft tolerance, as well as novel efforts to expand the utility of normothermic machine perfusion for use in solid organ transplantation.